<DOC>
	<DOCNO>NCT00885820</DOCNO>
	<brief_summary>This multicentre randomize , control trial ( RCT ) compare renal allograft histology function subject treat Tacrolimus + MMF + prednisone undergo early protocol biopsy treatment subclinical rejection versus non-protocol biopsy control group .</brief_summary>
	<brief_title>Benefit Early Protocol Biopsy Treatment Subclinical Rejection</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Subject recipient first second cadaveric living donor mismatch ( least one mismatch ) renal transplant If female childbearing potential , subject negative pregnancy test utilizes adequate contraceptive method Recipients kidney donor 65 year age Recipient nonrelated donor kidney peak pretransplant PRA &gt; 50 Subject lose previous graft rejection less one year transplant Subject receive investigational drug within three month prior randomization Subjects pregnant breastfeeding Subject receive kidney lack preimplantation biopsy Subject significant disease disability ( e.g . malignancy uncontrolled infection ) prevent adherence protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Graft Survival</keyword>
</DOC>